stay updated with our newsletter

Link between Gut Microbiome and Kidney Cancer Treatment Outcomes

kidney cancer

Physicians at City of Hope, working in collaboration with scientists at Translational Genomics Research Institute (TGen), have found that greater gut microbial diversity in patients with metastatic kidney cancer is associated with better treatment outcomes on Food and Drug Administration-approved immunotherapy regimens. Their findings are outlined in a study publishedRead

Inflammatory Cytokine Markers Predict COVID Severity and Survival

PCOS

Mount Sinai scientists have identified primary markers of inflammation IL-6 and TNF-α reliably predict COVID severity and likelihood of survival. This is providing a foundation for a diagnostic platform and therapeutic targets, according to a study published in Nature Medicine. The researchers studied four proteins serum interleukin (IL)-6, IL-8, tumorRead

JOIN OUR MAILING LIST

Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.